- The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry 2006 Jun; 45(6):642-57. Authors: Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. Summary: The panel developed agreed-upon algorithms for ADHD treatment with and without comorbid disorders. The major changes included elimination of pemoline as a treatment option, adding atomoxetine to the algorithm, and refining guidelines for treating ADHD with comorbid depression, aggressive behaviors, and tic disorders.
(+ View Article)
- Attention-deficit hyperactivity disorder. (Review)
Lancet. 2005 Jul 16-22;366(9481):237-48 Authors: Biederman J, Faraone SV
(+ View Article)
- Mental health in the United States: Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder --- United States, 2003
(+ View Article)
- Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers.
J Dev Behav Pediatr. 2001 Feb;22(1):60-73. Authors: Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T Summary: Five hundred seventy-nine children were randomly assigned to either routine community care monthly medication management, intensive behavioral treatment, and combination treatments. Results indicated that Combination and medication management interventions were substantially superior to behavioral and community care interventions for attention-deficit hyperactivity disorder symptoms.
(+ View Article)
- The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: Tactics. Attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry 2000 Jul; 39(7):920-7. Authors: Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG Summary: The conference developed by consensus and algorithm that broadly outlined the choice of medication for ADHD and some of its most common comorbid conditions. Specific tactical recommendations were developed with regard to medication dosage, assessment of drug response, management of side effects, and long-term medication management.
(+ View Article)
Brochures - Quotient™ ADHD System